Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Japanese MHLW adds fenofibrate tablets to NHI price list

Sep. 23, 2011

Clinical investigation of NPSP-558 for hypoparathyroidism updated

Sep. 23, 2011

Repros Therapeutics' study of low-dose oral Proellex advances

Sep. 22, 2011

Boehringer Ingelheim discloses novel Mnk inhibitors

Sep. 22, 2011

Findings disclosed from post hoc subanalysis of SYNCHRONY study

Sep. 22, 2011

Orexigen receives design requirements from FDA for cardiovascular outcomes trial of Contrave

Sep. 22, 2011

Expanded data presented from ORACAL trial of oral versus nasal salmon calcitonin

Sep. 22, 2011

PX-102 enters clinical development

Sep. 21, 2011

Novo Nordisk claims new melanocortin receptor modulators

Sep. 21, 2011

Novel Mnk inhibitors synthesized at Boehringer Ingelheim Pharma

Sep. 21, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 6, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...
Bio Korea 2026: US policy risks shift to execution framework
BioWorld
Regulatory uncertainty that dominated the life science sector in 2025 is transitioning into an execution framework for biotechnology companies, provided companies...
Regulatory actions for May 5, 2026
BioWorld
Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Adma, Applied...